News Focus
News Focus
icon url

go seek

10/23/13 8:52 AM

#18803 RE: zumantu #18801

The best action for AMARIN is to seek a 'conditional' approval of the ANCHOR indication.

This said not knowing the company or agency communication to date.
icon url

jessellivermore

10/23/13 9:24 AM

#18809 RE: zumantu #18801

Thank you zum

I feel as if I have been a small voice crying in the wilderness..

Everybody looks at this and says oh it's OK, or its the company's fault, or the company's fault for going it alone..I say no, the company has done nothing wrong here.

The FDA has an agenda here, and somebody, or some company is behind this. So far all we have is a successful stock manipulation, and we know from the options actions that somebody had access to confidential FDA information. Nobody puts up that kind of money on Zombie options without insider information.

Follow the money and you will find the culprits..The company's lawyers should be asking for a full investigation by the SEC.

I doubt the principals inside the FDA have the balls to follow through and kill the SPA agreement. That's going to mean federal court and they are not going to be able to pull off the shit they did in their own Kangaroo court. Best guess they put some face saving measure a minor amendment to the sNDA and its back to business as usual. You see when you throw the stock market action in with this you bring criminal into play..and these bureaucrats don't want to end up in jail.

A federal trial involving stock market manipulation, and FDA subversion is going to make headlines for AMRN and it is going to give Vascepa the kind of publicity that money can not buy..

Also it only takes one congressman to pull the trigger and start a congressional investigation of the whole matter..Would a congressman be interested in doing this..Well you have to ask yourself one question, "Do congressman like publicity?"...Well do they..

":>) JL